What is MapLight Therapeutics, Inc. 's short-term investments?

MapLight Therapeutics, Inc. (MPLT) reported short-term investments of $254.41M in Q1 2026.

What does short-term investments mean?

Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

MapLight Therapeutics, Inc. MPLT Short-Term Investments

Short-Term Investments at other companies

Bristol-Myers SquibbBMY

$912M+0.6%

Johnson & JohnsonJNJ

$363M+18.2%

Neurocrine BiosciencesNBIX

$1.05B+40.1%

Acadia PharmaceuticalsACAD

$569.25M+22.7%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$44.96M—

Xenon PharmaceuticalsXENE

$548.88M+26.8%

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's short-term investments?: MapLight Therapeutics, Inc. (MPLT) reported short-term investments of $254.41M in Q1 2026.
What does short-term investments mean?: Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.